US 9850542
Gene signature to predict homologous recombination (HR) deficient cancer
granted A61KA61K31/167A61K31/436
Quick answer
US patent 9850542 (Gene signature to predict homologous recombination (HR) deficient cancer) held by The Board of Regents of the University of Texas System expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/167, A61K31/436, A61K31/502, A61K31/5377